Super-strength MRI identifies neurodegeneration in Parkinson’s disease
A novel, ultra-powerful MRI scanner helps to pinpoint Parkinson’s disease and identify patients who are most likely to benefit from new treatments.
Parkinson’s disease and similar conditions are associated with cognitive symptoms that are difficult to treat. In a recent publication, a research group from the University of Cambridge (UK) has used a high power MRI scanner at the Wolfson Brain Imaging Center (Cambridge, UK) to visualize the locus coeruleus – a noradrenaline-producing center of the brain that is associated with these cognitive symptoms – thus helping to identify patients who will benefit most from noradrenaline-boosting drugs.
